Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Macrophages play important roles in liver injury and fibrosis during the progression of non-alcoholic steatohepatitis (NASH). In this study we try to establish effective delivery system into macrophages, and elucidate whether TNF-α siRNA complexed with schizophyllan (TNFα-SPG) inhibit liver inflammation and fibrosis in murine NASH models. We confirmed siRNA complexed with SPG can be specifically delivered into macrophage. In addition, TNFα-SPG successfully ameliorate inflammation, fibrosis, apoptosis, and ROS production in murine NASH model. Our result demonstrated a possible new therapeutic approach on macrophages by administration of siRNA-SPG for treatment of NASH.
|